Pricing Log in Create free account

Inovio Pharmaceuticals, Inc. (INO) vs Oramed Pharmaceuticals Inc. (ORMP)

Inovio Pharmaceuticals, Inc. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Inovio Pharmaceuticals, Inc. and Oramed Pharmaceuticals Inc. are of similar size ($171.8M and $167.5M). Inovio Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 48.8% against −54.8%. Across the 14 metrics below, Oramed Pharmaceuticals Inc. leads on 11 and Inovio Pharmaceuticals, Inc. on 3.

Valuation

Metric INO ORMP Biotechnology median
P/E n/m 0.93 10.26
P/S 310.99 40.01 9.18
P/B 27.45 0.51 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 259.00 27.42 8.98
Earnings yield (78.57%) 107.91% (34.89%)
Free cash flow yield (66.73%) (3.24%) (24.52%)

Profitability

Metric INO ORMP Biotechnology median
Gross margin 100.00% 32.31% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (409.87%) 73.90% (50.12%)
Return on assets (114.64%) 65.52% (45.60%)
Return on invested capital 0.00% (3.40%) 0.00%

Growth

Metric INO ORMP Biotechnology median
Revenue growth (TTM) (54.82%) 48.76% 6.26%
EPS growth (last fiscal year) 54.18% 412.50% 29.88%
Revenue growth, 5-year CAGR (61.18%) (5.85%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INO ORMP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.00 4.98 4.89
Net debt to EBITDA 0.70 8.41 1.01

Dividend

Metric INO ORMP Biotechnology median
Dividend yield — 6.38% 0.41%
Payout ratio — 0.06 —

Size

Metric INO ORMP Biotechnology median
Market cap 167.50m 171.80m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack